Summary
Pharmaceutical Testing Service is often used to identify the chemical composition and molecular structure of each individual substance contained in a medication.
This knowledge provides insight into a drug's performance and safety considerations. Pharmaceutical testing can reveal a pharmaceutical's solubility and can predict the medication's ability to reach a specific target within the body. Testing may even reveal contamination in the manufacturing production process or highlight other, previously unknown risks with the formulation.
Pharmaceutical Testing Services include raw materials testing, in-process and product release testing, finished pharmaceutical products testing and environmental samples, etc. It is mainly used in analytical testing, method development, stability testing and so on, the end users are like pharmaceutical factory, medical institution, government of health department, etc.
According to APO Research, The global Pharmaceutical Testing Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pharmaceutical Testing Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pharmaceutical Testing Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pharmaceutical Testing Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pharmaceutical Testing Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Pharmaceutical Testing Services include Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, Envigo, PPD, Element (Exova), ALS Pharmaceutical and Intertek Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Pharmaceutical Testing Services, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pharmaceutical Testing Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical Testing Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmaceutical Testing Services revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pharmaceutical Testing Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pharmaceutical Testing Services revenue, projected growth trends, production technology, application and end-user industry.
Pharmaceutical Testing Services segment by Company
Eurofins
WuXi AppTec
Pace Analytical Services
Catalent
Envigo
PPD
Element (Exova)
ALS Pharmaceutical
Intertek Group
SGS
Boston Analytical
EAG
DYNALABS
Maxxam
ARLBioPharma
West Pharmaceutical
BioScreen
Microbac
RD Laboratories
Analytical Lab Group
Piramal Pharma Solutions
Pharmaceutical Testing Services segment by Type
Raw Materials Testing
In-Process and Product Release Testing
Finished Pharmaceutical Products Testing
Environmental Samples
Others
Pharmaceutical Testing Services segment by Application
Analytical Testing
Method Development
Stability Testing
Pharmaceutical Testing Services segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Testing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pharmaceutical Testing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pharmaceutical Testing Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Testing Services revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Pharmaceutical Testing Services Market by Type
1.2.1 Global Pharmaceutical Testing Services Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Raw Materials Testing
1.2.3 In-Process and Product Release Testing
1.2.4 Finished Pharmaceutical Products Testing
1.2.5 Environmental Samples
1.2.6 Others
1.3 Pharmaceutical Testing Services Market by Application
1.3.1 Global Pharmaceutical Testing Services Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Analytical Testing
1.3.3 Method Development
1.3.4 Stability Testing
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Pharmaceutical Testing Services Market Dynamics
2.1 Pharmaceutical Testing Services Industry Trends
2.2 Pharmaceutical Testing Services Industry Drivers
2.3 Pharmaceutical Testing Services Industry Opportunities and Challenges
2.4 Pharmaceutical Testing Services Industry Restraints
3 Global Growth Perspective
3.1 Global Pharmaceutical Testing Services Market Perspective (2019-2030)
3.2 Global Pharmaceutical Testing Services Growth Trends by Region
3.2.1 Global Pharmaceutical Testing Services Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Pharmaceutical Testing Services Market Size by Region (2019-2024)
3.2.3 Global Pharmaceutical Testing Services Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Pharmaceutical Testing Services Revenue by Players
4.1.1 Global Pharmaceutical Testing Services Revenue by Players (2019-2024)
4.1.2 Global Pharmaceutical Testing Services Revenue Market Share by Players (2019-2024)
4.1.3 Global Pharmaceutical Testing Services Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Pharmaceutical Testing Services Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Pharmaceutical Testing Services Key Players Headquarters & Area Served
4.4 Global Pharmaceutical Testing Services Players, Product Type & Application
4.5 Global Pharmaceutical Testing Services Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Pharmaceutical Testing Services Market CR5 and HHI
4.6.2 Global Top 5 and 10 Pharmaceutical Testing Services Players Market Share by Revenue in 2023
4.6.3 2023 Pharmaceutical Testing Services Tier 1, Tier 2, and Tier 3
5 Pharmaceutical Testing Services Market Size by Type
5.1 Global Pharmaceutical Testing Services Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Pharmaceutical Testing Services Revenue by Type (2019-2030)
5.3 Global Pharmaceutical Testing Services Revenue Market Share by Type (2019-2030)
6 Pharmaceutical Testing Services Market Size by Application
6.1 Global Pharmaceutical Testing Services Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Pharmaceutical Testing Services Revenue by Application (2019-2030)
6.3 Global Pharmaceutical Testing Services Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Eurofins
7.1.1 Eurofins Comapny Information
7.1.2 Eurofins Business Overview
7.1.3 Eurofins Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.1.4 Eurofins Pharmaceutical Testing Services Product Portfolio
7.1.5 Eurofins Recent Developments
7.2 WuXi AppTec
7.2.1 WuXi AppTec Comapny Information
7.2.2 WuXi AppTec Business Overview
7.2.3 WuXi AppTec Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.2.4 WuXi AppTec Pharmaceutical Testing Services Product Portfolio
7.2.5 WuXi AppTec Recent Developments
7.3 Pace Analytical Services
7.3.1 Pace Analytical Services Comapny Information
7.3.2 Pace Analytical Services Business Overview
7.3.3 Pace Analytical Services Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.3.4 Pace Analytical Services Pharmaceutical Testing Services Product Portfolio
7.3.5 Pace Analytical Services Recent Developments
7.4 Catalent
7.4.1 Catalent Comapny Information
7.4.2 Catalent Business Overview
7.4.3 Catalent Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.4.4 Catalent Pharmaceutical Testing Services Product Portfolio
7.4.5 Catalent Recent Developments
7.5 Envigo
7.5.1 Envigo Comapny Information
7.5.2 Envigo Business Overview
7.5.3 Envigo Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.5.4 Envigo Pharmaceutical Testing Services Product Portfolio
7.5.5 Envigo Recent Developments
7.6 PPD
7.6.1 PPD Comapny Information
7.6.2 PPD Business Overview
7.6.3 PPD Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.6.4 PPD Pharmaceutical Testing Services Product Portfolio
7.6.5 PPD Recent Developments
7.7 Element (Exova)
7.7.1 Element (Exova) Comapny Information
7.7.2 Element (Exova) Business Overview
7.7.3 Element (Exova) Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.7.4 Element (Exova) Pharmaceutical Testing Services Product Portfolio
7.7.5 Element (Exova) Recent Developments
7.8 ALS Pharmaceutical
7.8.1 ALS Pharmaceutical Comapny Information
7.8.2 ALS Pharmaceutical Business Overview
7.8.3 ALS Pharmaceutical Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.8.4 ALS Pharmaceutical Pharmaceutical Testing Services Product Portfolio
7.8.5 ALS Pharmaceutical Recent Developments
7.9 Intertek Group
7.9.1 Intertek Group Comapny Information
7.9.2 Intertek Group Business Overview
7.9.3 Intertek Group Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.9.4 Intertek Group Pharmaceutical Testing Services Product Portfolio
7.9.5 Intertek Group Recent Developments
7.10 SGS
7.10.1 SGS Comapny Information
7.10.2 SGS Business Overview
7.10.3 SGS Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.10.4 SGS Pharmaceutical Testing Services Product Portfolio
7.10.5 SGS Recent Developments
7.11 Boston Analytical
7.11.1 Boston Analytical Comapny Information
7.11.2 Boston Analytical Business Overview
7.11.3 Boston Analytical Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.11.4 Boston Analytical Pharmaceutical Testing Services Product Portfolio
7.11.5 Boston Analytical Recent Developments
7.12 EAG
7.12.1 EAG Comapny Information
7.12.2 EAG Business Overview
7.12.3 EAG Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.12.4 EAG Pharmaceutical Testing Services Product Portfolio
7.12.5 EAG Recent Developments
7.13 DYNALABS
7.13.1 DYNALABS Comapny Information
7.13.2 DYNALABS Business Overview
7.13.3 DYNALABS Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.13.4 DYNALABS Pharmaceutical Testing Services Product Portfolio
7.13.5 DYNALABS Recent Developments
7.14 Maxxam
7.14.1 Maxxam Comapny Information
7.14.2 Maxxam Business Overview
7.14.3 Maxxam Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.14.4 Maxxam Pharmaceutical Testing Services Product Portfolio
7.14.5 Maxxam Recent Developments
7.15 ARLBioPharma
7.15.1 ARLBioPharma Comapny Information
7.15.2 ARLBioPharma Business Overview
7.15.3 ARLBioPharma Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.15.4 ARLBioPharma Pharmaceutical Testing Services Product Portfolio
7.15.5 ARLBioPharma Recent Developments
7.16 West Pharmaceutical
7.16.1 West Pharmaceutical Comapny Information
7.16.2 West Pharmaceutical Business Overview
7.16.3 West Pharmaceutical Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.16.4 West Pharmaceutical Pharmaceutical Testing Services Product Portfolio
7.16.5 West Pharmaceutical Recent Developments
7.17 BioScreen
7.17.1 BioScreen Comapny Information
7.17.2 BioScreen Business Overview
7.17.3 BioScreen Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.17.4 BioScreen Pharmaceutical Testing Services Product Portfolio
7.17.5 BioScreen Recent Developments
7.18 Microbac
7.18.1 Microbac Comapny Information
7.18.2 Microbac Business Overview
7.18.3 Microbac Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.18.4 Microbac Pharmaceutical Testing Services Product Portfolio
7.18.5 Microbac Recent Developments
7.19 RD Laboratories
7.19.1 RD Laboratories Comapny Information
7.19.2 RD Laboratories Business Overview
7.19.3 RD Laboratories Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.19.4 RD Laboratories Pharmaceutical Testing Services Product Portfolio
7.19.5 RD Laboratories Recent Developments
7.20 Analytical Lab Group
7.20.1 Analytical Lab Group Comapny Information
7.20.2 Analytical Lab Group Business Overview
7.20.3 Analytical Lab Group Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.20.4 Analytical Lab Group Pharmaceutical Testing Services Product Portfolio
7.20.5 Analytical Lab Group Recent Developments
7.21 Piramal Pharma Solutions
7.21.1 Piramal Pharma Solutions Comapny Information
7.21.2 Piramal Pharma Solutions Business Overview
7.21.3 Piramal Pharma Solutions Pharmaceutical Testing Services Revenue and Gross Margin (2019-2024)
7.21.4 Piramal Pharma Solutions Pharmaceutical Testing Services Product Portfolio
7.21.5 Piramal Pharma Solutions Recent Developments
8 North America
8.1 North America Pharmaceutical Testing Services Revenue (2019-2030)
8.2 North America Pharmaceutical Testing Services Revenue by Type (2019-2030)
8.2.1 North America Pharmaceutical Testing Services Revenue by Type (2019-2024)
8.2.2 North America Pharmaceutical Testing Services Revenue by Type (2025-2030)
8.3 North America Pharmaceutical Testing Services Revenue Share by Type (2019-2030)
8.4 North America Pharmaceutical Testing Services Revenue by Application (2019-2030)
8.4.1 North America Pharmaceutical Testing Services Revenue by Application (2019-2024)
8.4.2 North America Pharmaceutical Testing Services Revenue by Application (2025-2030)
8.5 North America Pharmaceutical Testing Services Revenue Share by Application (2019-2030)
8.6 North America Pharmaceutical Testing Services Revenue by Country
8.6.1 North America Pharmaceutical Testing Services Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Pharmaceutical Testing Services Revenue by Country (2019-2024)
8.6.3 North America Pharmaceutical Testing Services Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 Europe
9.1 Europe Pharmaceutical Testing Services Revenue (2019-2030)
9.2 Europe Pharmaceutical Testing Services Revenue by Type (2019-2030)
9.2.1 Europe Pharmaceutical Testing Services Revenue by Type (2019-2024)
9.2.2 Europe Pharmaceutical Testing Services Revenue by Type (2025-2030)
9.3 Europe Pharmaceutical Testing Services Revenue Share by Type (2019-2030)
9.4 Europe Pharmaceutical Testing Services Revenue by Application (2019-2030)
9.4.1 Europe Pharmaceutical Testing Services Revenue by Application (2019-2024)
9.4.2 Europe Pharmaceutical Testing Services Revenue by Application (2025-2030)
9.5 Europe Pharmaceutical Testing Services Revenue Share by Application (2019-2030)
9.6 Europe Pharmaceutical Testing Services Revenue by Country
9.6.1 Europe Pharmaceutical Testing Services Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Pharmaceutical Testing Services Revenue by Country (2019-2024)
9.6.3 Europe Pharmaceutical Testing Services Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Pharmaceutical Testing Services Revenue (2019-2030)
10.2 China Pharmaceutical Testing Services Revenue by Type (2019-2030)
10.2.1 China Pharmaceutical Testing Services Revenue by Type (2019-2024)
10.2.2 China Pharmaceutical Testing Services Revenue by Type (2025-2030)
10.3 China Pharmaceutical Testing Services Revenue Share by Type (2019-2030)
10.4 China Pharmaceutical Testing Services Revenue by Application (2019-2030)
10.4.1 China Pharmaceutical Testing Services Revenue by Application (2019-2024)
10.4.2 China Pharmaceutical Testing Services Revenue by Application (2025-2030)
10.5 China Pharmaceutical Testing Services Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Pharmaceutical Testing Services Revenue (2019-2030)
11.2 Asia Pharmaceutical Testing Services Revenue by Type (2019-2030)
11.2.1 Asia Pharmaceutical Testing Services Revenue by Type (2019-2024)
11.2.2 Asia Pharmaceutical Testing Services Revenue by Type (2025-2030)
11.3 Asia Pharmaceutical Testing Services Revenue Share by Type (2019-2030)
11.4 Asia Pharmaceutical Testing Services Revenue by Application (2019-2030)
11.4.1 Asia Pharmaceutical Testing Services Revenue by Application (2019-2024)
11.4.2 Asia Pharmaceutical Testing Services Revenue by Application (2025-2030)
11.5 Asia Pharmaceutical Testing Services Revenue Share by Application (2019-2030)
11.6 Asia Pharmaceutical Testing Services Revenue by Country
11.6.1 Asia Pharmaceutical Testing Services Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Pharmaceutical Testing Services Revenue by Country (2019-2024)
11.6.3 Asia Pharmaceutical Testing Services Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Pharmaceutical Testing Services Revenue (2019-2030)
12.2 MEALA Pharmaceutical Testing Services Revenue by Type (2019-2030)
12.2.1 MEALA Pharmaceutical Testing Services Revenue by Type (2019-2024)
12.2.2 MEALA Pharmaceutical Testing Services Revenue by Type (2025-2030)
12.3 MEALA Pharmaceutical Testing Services Revenue Share by Type (2019-2030)
12.4 MEALA Pharmaceutical Testing Services Revenue by Application (2019-2030)
12.4.1 MEALA Pharmaceutical Testing Services Revenue by Application (2019-2024)
12.4.2 MEALA Pharmaceutical Testing Services Revenue by Application (2025-2030)
12.5 MEALA Pharmaceutical Testing Services Revenue Share by Application (2019-2030)
12.6 MEALA Pharmaceutical Testing Services Revenue by Country
12.6.1 MEALA Pharmaceutical Testing Services Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Pharmaceutical Testing Services Revenue by Country (2019-2024)
12.6.3 MEALA Pharmaceutical Testing Services Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Pharmaceutical Testing Services Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Raw Materials Testing Major Manufacturers
Table 2. In-Process and Product Release Testing Major Manufacturers
Table 3. Finished Pharmaceutical Products Testing Major Manufacturers
Table 4. Environmental Samples Major Manufacturers
Table 5. Others Major Manufacturers
Table 6. Global Pharmaceutical Testing Services Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Analytical Testing Major Manufacturers
Table 8. Method Development Major Manufacturers
Table 9. Stability Testing Major Manufacturers
Table 10. Pharmaceutical Testing Services Industry Trends
Table 11. Pharmaceutical Testing Services Industry Drivers
Table 12. Pharmaceutical Testing Services Industry Opportunities and Challenges
Table 13. Pharmaceutical Testing Services Industry Restraints
Table 14. Global Pharmaceutical Testing Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 15. Global Pharmaceutical Testing Services Market Size by Region (2019-2024) & (US$ Million)
Table 16. Global Pharmaceutical Testing Services Market Share by Region (2019-2024)
Table 17. Global Pharmaceutical Testing Services Market Size by Region (2025-2030) & (US$ Million)
Table 18. Global Pharmaceutical Testing Services Market Share by Region (2025-2030)
Table 19. Global Pharmaceutical Testing Services Revenue by Players (US$ Million) & (2019-2024)
Table 20. Global Pharmaceutical Testing Services Revenue Market Share by Players (2019-2024)
Table 21. Global Pharmaceutical Testing Services Key Players Ranking, 2022 VS 2023 VS 2024
Table 22. Global Pharmaceutical Testing Services Key Players Headquarters & Area Served
Table 23. Global Pharmaceutical Testing Services Players, Product Type & Application
Table 24. Global Pharmaceutical Testing Services Players Commercialization Time
Table 25. Global Players Market Concentration Ratio (CR5 and HHI)
Table 26. Global Pharmaceutical Testing Services by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 27. Global Pharmaceutical Testing Services Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 28. Global Pharmaceutical Testing Services Revenue by Type (2019-2024) & (US$ Million)
Table 29. Global Pharmaceutical Testing Services Revenue by Type (2025-2030) & (US$ Million)
Table 30. Global Pharmaceutical Testing Services Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 31. Global Pharmaceutical Testing Services Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 32. Global Pharmaceutical Testing Services Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Pharmaceutical Testing Services Revenue by Application (2019-2024) & (US$ Million)
Table 34. Global Pharmaceutical Testing Services Revenue by Application (2025-2030) & (US$ Million)
Table 35. Global Pharmaceutical Testing Services Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 36. Global Pharmaceutical Testing Services Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 37. Eurofins Company Information
Table 38. Eurofins Business Overview
Table 39. Eurofins Pharmaceutical Testing Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 40. Eurofins Pharmaceutical Testing Services Product Portfolio
Table 41. Eurofins Recent Development
Table 42. WuXi AppTec Company Information
Table 43. WuXi AppTec Business Overview
Table 44. WuXi AppTec Pharmaceutical Testing Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 45. WuXi AppTec Pharmaceutical Testing Services Product Portfolio
Table 46. WuXi AppTec Recent Development
Table 47. Pace Analytical Services Company Information
Table 48. Pace Analytical Services Business Overview
Table 49. Pace Analytical Services Pharmaceutical Testing Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 50. Pace Analytical Services Pharmaceutical Testing Services Product Portfolio
Table 51. Pace Analytical Services Recent Development
Table 52. Catalent Company Information
Table 53. Catalent Business Overview
Table 54. Catalent Pharmaceutical Testing Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 55. Catalent Pharmaceutical Testing Services Product Portfolio
Table 56. Catalent Recent Development
Table 57. Envigo Company Information
Table 58. Envigo Business Overview
Table 59. Envigo Pharmaceutical Testing Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 60. Envigo Pharmaceutical Testing Services Product Portfolio
Table 61. Envigo Recent Development
Table 62. PPD Company Information
Table 63. PPD Business Overview
Table 64. PPD Pharmaceutical Testing Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 65. PPD Pharmaceutical Testing Services Product Portfolio
Table 66. PPD Recent Development
Table 67. Element (Exova) Company Information
Table 68. Element (Exova) Business Overview
Table 69. Element (Exova) Pharmaceutical Testing Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 70. Element (Exova) Pharmaceutical Testing Services Product Portfolio
Table 71. Element (Exova) Recent Development
Table 72. ALS Pharmaceutical Company Information
Table 73. ALS Pharmaceutical Business Overview
Table 74. ALS Pharmaceutical Pharmaceutical Testing Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 75. ALS Pharmaceutical Pharmaceutical Testing Services Product Portfolio
Table 76. ALS Pharmaceutical Recent Development
Table 77. Intertek Group Company Information
Table 78. Intertek Group Business Overview
Table 79. Intertek Group Pharmaceutical Testing Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 80. Intertek Group Pharmaceutical Testing Services Product Portfolio
Table 81. Intertek Group Recent Development
Table 82. SGS Company Information
Table 83. SGS Business Overview
Table 84. SGS Pharmaceutical Testing Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 85. SGS Pharmaceutical Testing Services Product Portfolio
Table 86. SGS Recent Development
Table 87. Boston Analytical Company Information
Table 88. Boston Analytical Business Overview
Table 89. Boston Analytical Pharmaceutical Testing Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Boston Analytical Pharmaceutical Testing Services Product Portfolio
Table 91. Boston Analytical Recent Development
Table 92. EAG Company Information
Table 93. EAG Business Overview
Table 94. EAG Pharmaceutical Testing Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. EAG Pharmaceutical Testing Services Product Portfolio
Table 96. EAG Recent Development
Table 97. DYNALABS Company Information
Table 98. DYNALABS Business Overview
Table 99. DYNALABS Pharmaceutical Testing Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. DYNALABS Pharmaceutical Testing Services Product Portfolio
Table 101. DYNALABS Recent Development
Table 102. Maxxam Company Information
Table 103. Maxxam Business Overview
Table 104. Maxxam Pharmaceutical Testing Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Maxxam Pharmaceutical Testing Services Product Portfolio
Table 106. Maxxam Recent Development
Table 107. ARLBioPharma Company Information
Table 108. ARLBioPharma Business Overview
Table 109. ARLBioPharma Pharmaceutical Testing Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. ARLBioPharma Pharmaceutical Testing Services Product Portfolio
Table 111. ARLBioPharma Recent Development
Table 112. West Pharmaceutical Company Information
Table 113. West Pharmaceutical Business Overview
Table 114. West Pharmaceutical Pharmaceutical Testing Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. West Pharmaceutical Pharmaceutical Testing Services Product Portfolio
Table 116. West Pharmaceutical Recent Development
Table 117. BioScreen Company Information
Table 118. BioScreen Business Overview
Table 119. BioScreen Pharmaceutical Testing Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. BioScreen Pharmaceutical Testing Services Product Portfolio
Table 121. BioScreen Recent Development
Table 122. Microbac Company Information
Table 123. Microbac Business Overview
Table 124. Microbac Pharmaceutical Testing Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Microbac Pharmaceutical Testing Services Product Portfolio
Table 126. Microbac Recent Development
Table 127. RD Laboratories Company Information
Table 128. RD Laboratories Business Overview
Table 129. RD Laboratories Pharmaceutical Testing Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. RD Laboratories Pharmaceutical Testing Services Product Portfolio
Table 131. RD Laboratories Recent Development
Table 132. Analytical Lab Group Company Information
Table 133. Analytical Lab Group Business Overview
Table 134. Analytical Lab Group Pharmaceutical Testing Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. Analytical Lab Group Pharmaceutical Testing Services Product Portfolio
Table 136. Analytical Lab Group Recent Development
Table 137. Piramal Pharma Solutions Company Information
Table 138. Piramal Pharma Solutions Business Overview
Table 139. Piramal Pharma Solutions Pharmaceutical Testing Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 140. Piramal Pharma Solutions Pharmaceutical Testing Services Product Portfolio
Table 141. Piramal Pharma Solutions Recent Development
Table 142. North America Pharmaceutical Testing Services Revenue by Type (2019-2024) & (US$ Million)
Table 143. North America Pharmaceutical Testing Services Revenue by Application (2019-2024) & (US$ Million)
Table 144. North America Pharmaceutical Testing Services Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 145. North America Pharmaceutical Testing Services Revenue by Country (2019-2024) & (US$ Million)
Table 146. North America Pharmaceutical Testing Services Revenue by Country (2025-2030) & (US$ Million)
Table 147. Europe Pharmaceutical Testing Services Revenue by Type (2019-2024) & (US$ Million)
Table 148. Europe Pharmaceutical Testing Services Revenue by Application (2019-2024) & (US$ Million)
Table 149. Europe Pharmaceutical Testing Services Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 150. Europe Pharmaceutical Testing Services Revenue by Country (2019-2024) & (US$ Million)
Table 151. Europe Pharmaceutical Testing Services Revenue by Country (2025-2030) & (US$ Million)
Table 152. China Pharmaceutical Testing Services Revenue by Type (2019-2024) & (US$ Million)
Table 153. China Pharmaceutical Testing Services Revenue by Application (2019-2024) & (US$ Million)
Table 154. Asia Pharmaceutical Testing Services Revenue by Type (2019-2024) & (US$ Million)
Table 155. Asia Pharmaceutical Testing Services Revenue by Application (2019-2024) & (US$ Million)
Table 156. Asia Pharmaceutical Testing Services Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 157. Asia Pharmaceutical Testing Services Revenue by Country (2019-2024) & (US$ Million)
Table 158. Asia Pharmaceutical Testing Services Revenue by Country (2025-2030) & (US$ Million)
Table 159. MEALA Pharmaceutical Testing Services Revenue by Type (2019-2024) & (US$ Million)
Table 160. MEALA Pharmaceutical Testing Services Revenue by Application (2019-2024) & (US$ Million)
Table 161. MEALA Pharmaceutical Testing Services Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 162. MEALA Pharmaceutical Testing Services Revenue by Country (2019-2024) & (US$ Million)
Table 163. MEALA Pharmaceutical Testing Services Revenue by Country (2025-2030) & (US$ Million)
Table 164. Research Programs/Design for This Report
Table 165. Authors List of This Report
Table 166. Secondary Sources
Table 167. Primary Sources
List of Figures
Figure 1. Pharmaceutical Testing Services Product Picture
Figure 2. Global Pharmaceutical Testing Services Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pharmaceutical Testing Services Market Size Share 2019 VS 2023 VS 2030
Figure 4. Raw Materials Testing Picture
Figure 5. In-Process and Product Release Testing Picture
Figure 6. Finished Pharmaceutical Products Testing Picture
Figure 7. Environmental Samples Picture
Figure 8. Others Picture
Figure 9. Global Pharmaceutical Testing Services Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 10. Global Pharmaceutical Testing Services Market Size Share 2019 VS 2023 VS 2030
Figure 11. Analytical Testing Picture
Figure 12. Method Development Picture
Figure 13. Stability Testing Picture
Figure 14. Global Pharmaceutical Testing Services Market Size (US$ Million) & (2019-2030)
Figure 15. Global Pharmaceutical Testing Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Pharmaceutical Testing Services Market Share by Region: 2019 VS 2023 VS 2030
Figure 17. Global Pharmaceutical Testing Services Players Revenue Share Top 10 and Top 5 in 2023
Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. Global Pharmaceutical Testing Services Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Pharmaceutical Testing Services Revenue Market Share 2019 VS 2023 VS 2030
Figure 21. Global Pharmaceutical Testing Services Revenue Market Share by Type (2019-2030)
Figure 22. Global Pharmaceutical Testing Services Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Pharmaceutical Testing Services Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 24. Global Pharmaceutical Testing Services Revenue Market Share by Application (2019-2030)
Figure 25. North America Pharmaceutical Testing Services Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 26. North America Pharmaceutical Testing Services Revenue by Type (2025-2030) & (US$ Million)
Figure 27. North America Pharmaceutical Testing Services Revenue Share by Type (2019-2030)
Figure 28. North America Pharmaceutical Testing Services Revenue by Application (2025-2030) & (US$ Million)
Figure 29. North America Pharmaceutical Testing Services Revenue Share by Application (2019-2030)
Figure 30. North America Pharmaceutical Testing Services Revenue Share by Country (2019-2030)
Figure 31. United States Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 32. Canada Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 33. Europe Pharmaceutical Testing Services Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 34. Europe Pharmaceutical Testing Services Revenue by Type (2025-2030) & (US$ Million)
Figure 35. Europe Pharmaceutical Testing Services Revenue Share by Type (2019-2030)
Figure 36. Europe Pharmaceutical Testing Services Revenue by Application (2025-2030) & (US$ Million)
Figure 37. Europe Pharmaceutical Testing Services Revenue Share by Application (2019-2030)
Figure 38. Europe Pharmaceutical Testing Services Revenue Share by Country (2019-2030)
Figure 39. Germany Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. France Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. U.K. Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Italy Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. Russia Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. Nordic Countries Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 45. China Pharmaceutical Testing Services Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 46. China Pharmaceutical Testing Services Revenue by Type (2025-2030) & (US$ Million)
Figure 47. China Pharmaceutical Testing Services Revenue Share by Type (2019-2030)
Figure 48. China Pharmaceutical Testing Services Revenue by Application (2025-2030) & (US$ Million)
Figure 49. China Pharmaceutical Testing Services Revenue Share by Application (2019-2030)
Figure 50. Asia Pharmaceutical Testing Services Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 51. Asia Pharmaceutical Testing Services Revenue by Type (2025-2030) & (US$ Million)
Figure 52. Asia Pharmaceutical Testing Services Revenue Share by Type (2019-2030)
Figure 53. Asia Pharmaceutical Testing Services Revenue by Application (2025-2030) & (US$ Million)
Figure 54. Asia Pharmaceutical Testing Services Revenue Share by Application (2019-2030)
Figure 55. Asia Pharmaceutical Testing Services Revenue Share by Country (2019-2030)
Figure 56. Japan Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. South Korea Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. India Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. Australia Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. China Taiwan Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. Southeast Asia Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 62. MEALA Pharmaceutical Testing Services Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 63. MEALA Pharmaceutical Testing Services Revenue by Type (2025-2030) & (US$ Million)
Figure 64. MEALA Pharmaceutical Testing Services Revenue Share by Type (2019-2030)
Figure 65. MEALA Pharmaceutical Testing Services Revenue by Application (2025-2030) & (US$ Million)
Figure 66. MEALA Pharmaceutical Testing Services Revenue Share by Application (2019-2030)
Figure 67. MEALA Pharmaceutical Testing Services Revenue Share by Country (2019-2030)
Figure 68. Mexico Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. South Korea Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Brazil Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Israel Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Argentina Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Colombia Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Turkey Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. Saudi Arabia Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. UAE Pharmaceutical Testing Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 77. Years Considered
Figure 78. Research Process
Figure 79. Key Executives Interviewed
